General Information of the Compound
| Compound ID |
CP0880271
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-[(3-Fluoropyridin-2-yl)methyl]-2-(1-{2-[7-(trifluoromethyl)-1H-1,3-benzodiazol-2-yl]ethyl}azetidin-3-yl)-1,3-oxazole-4-carboxamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C23H20F4N6O2
|
||||||||||||||||||
| Molecular Weight |
488.445
|
||||||||||||||||||
| Canonical SMILES |
O=C(NCc1ncccc1F)c1coc(C2CN(CCc3nc4cccc(C(F)(F)F)c4[nH]3)C2)n1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C23H20F4N6O2/c24-15-4-2-7-28-17(15)9-29-21(34)18-12-35-22(31-18)13-10-33(11-13)8-6-19-30-16-5-1-3-14(20(16)32-19)23(25,26)27/h1-5,7,12-13H,6,8-11H2,(H,29,34)(H,30,32)
Show/Hide
|
||||||||||||||||||
| InChIKey |
SCXRAUWLUXXWNI-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT06104, Solute carrier family 40 member 1
Protein ID: PT06354, Solute carrier family 40 member 1